NASDAQ
27.06.25 | 18:26
1,000 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | IceCure Medical Ltd. - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 16.06. | IceCure Medical Ltd. - F-1, Registration statement for certain foreign private issuers | 3 | SEC Filings | ||
| 09.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 09.06. | IceCure Medical: IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes | 98 | PR Newswire | IceCure has 20+ patents in the U.S. and the Company anticipates further market traction upon FDA's marketing authorization decision in early-stage breast cancer
... ► Artikel lesen | |
| 30.05. | H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 | 1 | Investing.com | ||
| 29.05. | IceCure Medical GAAP EPS of -$0.06 beats by $0.01, revenue of $0.73M misses by $0.25M | 2 | Seeking Alpha | ||
| 28.05. | IceCure Medical Ltd Q1 Loss Decreases, Beats Estimates | - | RTTNews | ||
| 28.05. | IceCure Medical GAAP EPS of -$0.06 beats by $0.02, revenue of $0.73M misses by $0.02M | 3 | Seeking Alpha | ||
| 28.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.05. | IceCure Medical Reports First Quarter 2025 Financial Results | 99 | PR Newswire | Recently finalized and delivered proposed post market study plan to the FDA; Awaiting marketing authorization decision for ProSense® in women aged 70+ with early-stage... ► Artikel lesen | |
| 27.05. | Earnings Preview For Icecure Medical | 1 | Benzinga.com | ||
| 21.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 30.04. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.04. | IceCure Medical: IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense Cryoablation in Women 70+ with Early-Stage Breast Cancer | 84 | PR Newswire | Final marketing authorization decision for early-stage breast cancer is expected upon the FDA's approval of IceCure's post-market study plan
IceCure to engage... ► Artikel lesen | |
| 10.04. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 28.03. | IceCure Medical Stock Dips Despite Positive ICESECRET Study Results | 1 | Zacks | ||
| 28.03. | IceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
| 28.03. | H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target | 1 | Investing.com | ||
| 27.03. | IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense Cryoablation Sales in North America | 468 | PR Newswire | Expecting FDA decision on marketing authorization for early-stage low risk breast cancer with endocrine therapy
Positive ProSense® results were reported through... ► Artikel lesen |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 91,13 | 0,00 % | Why GeneDX Stock Surged Higher This Week | ||
| FRESENIUS | 42,650 | +0,14 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,090 | +0,41 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| PROGYNY | 21,910 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
| BRIGHTSPRING HEALTH SERVICES | 23,540 | 0,00 % | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy | ||
| FRESENIUS MEDICAL CARE | 48,340 | +0,08 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 56,91 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 1,960 | 0,00 % | Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology | Patent supports the Company's broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market opportunity... ► Artikel lesen | |
| LIFEMD | 13,760 | +1,62 % | LifeMD-Aktie steigt nach Fortsetzung der Wegovy-Partnerschaft mit Novo Nordisk | ||
| ALIGNMENT HEALTHCARE | 13,850 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| ADAPTHEALTH | 9,560 | 0,00 % | AdaptHealth Corp. - 10-K/A, Annual Report | ||
| LIFESTANCE HEALTH GROUP | 5,150 | 0,00 % | LifeStance Health: LifeStance Names Vaughn Paunovich as Chief Technology Officer | SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care... ► Artikel lesen | |
| CONCENTRA GROUP | 21,140 | +2,22 % | Concentra beruft zwei technologieversierte Gesundheitsexperten in den Vorstand | ||
| BONE BIOLOGICS | 4,560 | 0,00 % | Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share | ||
| CARL ZEISS MEDITEC | 57,10 | +0,18 % | Carl Zeiss Meditec AG: Chirurgische Präzision, strategische Genauigkeit; mwb research stuft auf KAUFEN | Carl Zeiss Meditec (CZM) bleibt ein weltweit führender Anbieter in der Augenheilkunde und Mikrochirurgie, gestützt durch strukturelle Wachstumstreiber wie demografischen Wandel und die Zunahme von Sehstörungen.... ► Artikel lesen |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.